yingweiwo

ZM-39923

Alias: ZM 39923 JAK3 inhibitor IV ZM-39923
Cat No.:V28525 Purity: ≥98%
ZM-39923 is a novel and potent Janus kinase inhibitor
ZM-39923
ZM-39923 Chemical Structure CAS No.: 273727-89-2
Product category: New1
This product is for research use only, not for human use. We do not sell to patients.
Size Price
500mg
1g
Other Sizes

Other Forms of ZM-39923:

  • ZM 39923 HCl
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description
ZM-39923 (ZM-39923) is a novel and potent inhibitor of Janus kinase-JAK1/3 with potential anti-inflammatory activity. It inhibits JAK1/3 with pIC50s of 4.4/7.1, and shows little/no activity against JAK2 and modestly potency to EGFR; also found to be sensitive to transglutaminase.
ZM-39923 (free base) is a potent inhibitor of Janus kinase 3 (JAK3) and tissue transglutaminase (TGM2). It has the molecular formula C23H25NO and a molecular weight of 331.45. ZM-39923 inhibits JAK3 with a pIC50 of 7.1 (IC50 ~79 nM) and TGM2 with an IC50 of 10 nM. It also inhibits Factor XIIIa (IC50 25 nM) and shows weak activity against EGFR, JAK1, and CDK4 (IC50 = 2.4, 40, and 10 μM, respectively). ZM-39923 is a valuable research tool for studying JAK/STAT signaling and transglutaminase biology, with potential anti-inflammatory and anticancer applications.
Biological Activity I Assay Protocols (From Reference)
Targets
Janus kinase 3 (JAK3), a tyrosine kinase essential for cytokine signaling through the common gamma chain (γc). JAK3 is primarily expressed in hematopoietic cells and is critical for lymphocyte development and function. ZM-39923 also inhibits tissue transglutaminase (TGM2), a calcium-dependent enzyme involved in protein cross-linking, cell adhesion, and apoptosis. Factor XIIIa is also inhibited. JAK3 inhibition blocks IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 signaling, while TGM2 inhibition affects extracellular matrix remodeling and cell survival.
ln Vitro
ZM39923 is a pIC50 of 7.1 JAK3 inhibitor. ZM39923 (compound 7) has no discernible inhibitory effect on tyrosine kinases Lck and CDK4 (pIC50<5.0), but it exhibits weak inhibitory effects on EGF-R and JAK1 (pIC50 are 5.6, 4.4, respectively) [1]. ZM39923 directly acts on purified TGM2, inhibiting the Ca2+-activated form of TGM2, and inhibits tissue transglutaminase (TGM2) with an IC50 of 10 nM[2]. ZM39923 has a similar effect to CCR7 antibodies in that it prevents JAK3 phosphorylation that is induced by CCL19. ZM39923 also considerably inhibits the migration and invasion of PCI-37B cells and blocks the rate of wound closure induced by CCL19 [3].
ZM-39923 is a potent JAK3 inhibitor with an IC50 of approximately 79 nM (pIC50 7.1). It also potently inhibits tissue transglutaminase (TGM2) with an IC50 of 10 nM and Factor XIIIa with an IC50 of 25 nM. It shows weak inhibitory activity against EGFR (IC50 2.4 μM), JAK1 (IC50 40 μM), and CDK4 (IC50 10 μM). ZM-39923 blocks JAK3 phosphorylation induced by CCL19 and inhibits CCL19-induced migration and invasion of PCI-37B cells. It also inhibits TGM2 activity directly.
ln Vivo
In vivo data for ZM-39923 are limited in publicly available literature. As a research tool, it has been primarily characterized in biochemical and cell-based assays. Its pharmacokinetic properties and in vivo efficacy have not been extensively studied. The compound's dual JAK3/TGM2 inhibition profile makes it attractive for evaluating in animal models of inflammatory diseases, fibrosis, and cancer. Further in vivo studies would be required to assess its therapeutic potential and optimal dosing regimens.
Enzyme Assay
For JAK3 kinase inhibition assays, recombinant JAK3 kinase domain is incubated with a peptide substrate in kinase assay buffer containing ATP. ZM-39923 is added at varying concentrations. Phosphorylated substrate is detected by ELISA or fluorescence polarization. For TGM2 inhibition assays, recombinant TGM2 is incubated with a fluorogenic substrate (e.g., CBZ-Gln-Gly) or [3H]putrescine and casein in the presence of calcium. ZM-39923 is added, and enzyme activity is measured by fluorescence or radioactivity.
Cell Assay
For cell-based assays, PCI-37B cells (a metastatic SCCHN cell line expressing CCR7) are cultured in DMEM with 10% FBS. ZM-39923 is added at varying concentrations. JAK3 phosphorylation induced by CCL19 is assessed by Western blot. Cell migration and invasion are measured using wound healing and Transwell assays. For TGM2 activity in cells, a fluorescent substrate is used. Cell viability is assessed by CCK-8 or MTT assay.
Animal Protocol
For in vivo evaluation, animal models of JAK3-dependent inflammation or TGM2-mediated fibrosis are used. ZM-39923 is administered intraperitoneally or orally at various doses. For inflammation models (e.g., collagen-induced arthritis, LPS-induced endotoxemia), inflammatory cytokine levels and tissue damage are assessed. For fibrosis models (e.g., bleomycin-induced lung fibrosis), collagen deposition is measured. Pharmacokinetic studies involve plasma sampling and LC-MS/MS quantification.
References

[1]. Naphthyl ketones: a new class of Janus kinase 3 inhibitors. Bioorg Med Chem Lett. 2000 Mar 20;10(6):575-9.

[2]. Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries. Chem Biol. 2008 Sep 22;15(9):969-78.

[3]. Jak3 is involved in CCR7-dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck. Oncol Lett. 2017 May;13(5):3191-3197.

Additional Infomation
1-(2-Naphthyl)-3-[(benzyl)-propyl-2-ylamino]-1-propanone is a naphthalene compound. ZM-39923 is a small molecule that inhibits Janus kinase and human tissue transglutaminase (TGM2).
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C23H25NO
Molecular Weight
331.45
Exact Mass
331.194
CAS #
273727-89-2
Related CAS #
ZM39923 hydrochloride;1021868-92-7
PubChem CID
3797
Appearance
Typically exists as solid at room temperature
LogP
5.323
tPSA
20.31
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
7
Heavy Atom Count
25
Complexity
412
Defined Atom Stereocenter Count
0
SMILES
O=C(C1=CC=C2C=CC=CC2=C1)CCN(C(C)C)CC3=CC=CC=C3
InChi Key
JSASWRWALCMOQP-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H25NO/c1-18(2)24(17-19-8-4-3-5-9-19)15-14-23(25)22-13-12-20-10-6-7-11-21(20)16-22/h3-13,16,18H,14-15,17H2,1-2H3
Chemical Name
3-[benzyl(propan-2-yl)amino]-1-naphthalen-2-ylpropan-1-one
Synonyms
ZM 39923 JAK3 inhibitor IV ZM-39923
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.0170 mL 15.0852 mL 30.1705 mL
5 mM 0.6034 mL 3.0170 mL 6.0341 mL
10 mM 0.3017 mL 1.5085 mL 3.0170 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us